The Prevention of Recurrent Episodes of Depression With Venlafaxine for Two Years (PREVENT) Study
Martín Keller(University of Basel), Philip T. Ninan(Emory University), Richard C. Shelton(University of Maryland, College Park), Bing Chun Yan(State Administration of Traditional Chinese Medicine of the People's Republic of China), Charles B. Nemeroff(The University of Texas at Austin), Alan F. Schatzberg(Stanford University), Susan G. Kornstein(Virginia Commonwealth University), James M. Ferguson(University of Utah), David L. Dünner, Madhukar H. Trivedi(Southwestern Medical Center), John Zajecka(Psychiatric Medicine Associates), Anthony J. Rothschild(UMass Memorial Health Care), Michael E. Thase(Veterans Health Administration), Alan J. Gelenberg(University of Arizona), Saeeduddin Ahmed(Pfizer (United States)), James H. Kocsis(Cornell University), Robert M. A. Hirschfeld(The University of Texas Medical Branch at Galveston), Jeff Musgnung(Pfizer (United States)), Ronald Pedersen, Edward S. Friedman(University of Pittsburgh)
Cited by 109
Related Papers
The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression
|Biological Psychiatry|2003|3.9k
Lifetime and 12-Month Prevalence of Bipolar Spectrum Disorder in the National Comorbidity Survey Replication
|Archives of General Psychiatry|2007|2.4k
Resting-state connectivity biomarkers define neurophysiological subtypes of depression
|Nature Medicine|2016|2.2k
Major depressive disorder
|Nature Reviews Disease Primers|2016|2.1k